High-performance liquid chromatography with fluorescence detection has been utilized for the rapid determination of total homocysteine, cysteine, and cysteinyiglycine in human serum and plasma. Our earlier procedure (Anal Biochem 1989;1 78:208), which used monobromobimane to specifically derivatize thiols, has been extensively modified to allow for rapid processing of samples. As a result, >80 samples a day can be assayed for total homocysteine, cysteine, and cysteinylglycine. The method is sensitive (lower limitof detection 4 pmol in the assay) and precise (intra-and interassay CV for homocysteine, 3.31% and 4.85%, respectively). Mean total homocysteine concentrations in plasma and serum were significantlydifferent, bothfrom healthy male donors (9.26 and 12.30 mol/L, respectively: P <0.001) and healthy female donors (7.85 and 10.34 j.mol/L, respectively; P <0.001). The differences in total homocysteine between sexes were also significant (P = 0.002 for both plasma and serum). Similar differences were found for cysteine and cysteinylglycine. We found a significant inverse correlation between serum cobalamin and total homocysteine in men (P = 0.0102) and women (P = 0.0174).
ported an association between milder degrees of hyperhomocysteinemia and coronary artery disease (11, 12), cerebrovascular disease (13, 14) , and peripheral arterial occlusive disease (14, 15) . In many of these studies, hyperhomocysteinemia was an independent risk factor for the cardiovascular disease (11, 14, 15). disease patients at large, will require rapid and reproducible assays. Early studies of plasma from patients with homocystinuria reported an assortment of at normal sulfur-bearing amino acids, including homoc3stine
and homocysteine-cysteine mixed disulfide, whi(h, at the time, were undetectable in normal plasma (2.5). Only later were these metabolites also found in not mal plasma at very low concentrations (26) (27) (28) .
It is now known that 75-90% of the homocysteine in normal lasma is covalently bound to plasma proteins by disulfide bonds (29) (30) (31) . To determine total plasma homocysteine-the sum of all protein-bound forms, oxidized low-molecular-mass forms, and free reduced homocysteu Le-it is necessary to reduce disulfide bonds.
An early radioenzymatic method for total plasma homocysteine included dithioerythriol as the reducing agent to break disulfide bonds (30) . More recent methods for determining total plasma homocysteine have utilized 2-mercaptoethanol as the reducing agent and gas chromatography-mass spectrometry (32); sodium borohydride as the reducing agent and monobromobimane as the thiol-specific fluorochromophore, followed by HPLC with fluorescence detection (FD) ( 
31, 33, 34);
tri-n-butylphosphine as the reducing agent and ammomum 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate as the fiuorochromophore, followed by HPLC-FD (35) (36) (37) and Cys(-S-bimane)Gly are similar to that of homocysteine-S-bimane, we estimate the detection sensitivity for these analytes to be at least 10 pmol.
Results

Assay Performance
Determination
Precision. The intraassay CV for total serum homocysteine, cysteine, and CysGly was determined by including normal-concentration quality-control serum (n
Fig. 1. HPLC-FD of thiol-bimane standards (A), normal human serum (B), and hyperhomocysteinemic serum (C).
(A) A mixture of standards, including purified cysteine-S-bimane
(Cys), Cys(-S-bimane)Gly (CysGIy), homocysteine-S-bimane (Hcy),
and glutathione-S-bimane (GSH) was eluted from the column with a methanol gradient(-) as described in Materialsand Methods. Total cysteine, CysGIy, and homocysteine were determinedin normal human serum (B) orin hyperhomocysteinemic serum (C) and analyzed by HPLC-FDas described inthetext.The gradientusedwas identical tothat in A except that the isocratic segmentfrom 9 to 10 mm was omitted. When the difference between the HPLC-ED and HPLC-FD means was plotted against the mean of the HPLC-ED and HPLC-FD means, there was good agreement and no bias between the two methods (Fig. 3B) . That is, the two methods would disagree by no more than 3 moI/L with 95% confidence.
Characterization of Thiol-BimaneStandards
The absorbance spectrum of HPLC-purifled homocysteine-S-bimane exhibited absorbance maxima at 234 nm (relative absorbance The mean (± SD) total homecysteine in plasma and serum from men (see Table 1 
The ranges (mean ±2 SD) for total plasma and serum homocysteine were 3.27 to 12.43 and 3.92 to 16.84 tmolJL, respectively ( Table 1) .
For every donor in this study, the total plasma homocysteine concentration was less than the total serum homocysteine concentration.
The differences between men's and women's mean plasma and serum total homocysteine concentrations were significant: P = 0.002 for both plasma and serum ( Table 1) .
Men showed a significant negative correlation (Pearson) between serum cobalaniin and total plasma homecysteine (r = -0.499, P = 0.0019) and between serum cobilamin and total serum homocysteine (r = -0.423, P = 0.0102). In women the negative correlation betwee serum cobalamin and total serum homocysteine w significant (r = -0.400, P = 0.0174), but not betwee total plasma homocysteine and serum cobalainin (r = -0.254, P = 0.1411). There were also significant negative correlations between serum total homocysteine an serum folate in men and women (r = -0.356, P = 0.0330; and r = -0.360, P = 0.0337, respectively) and between plasma total homocysteine and serum folate = -0.3059, P = 0.070; and r = -0.409, P = 0.0147, respectively).
Results
of linear regression analyses
between serum homocysteine and serum cobalamin and folate by sex are shown in Fig. 5 .
Cysteine. The plasma and serum values for total cysteine in healthy men and women were normally distrib- Table 1 ). The plasma/serum difference was highly significant in women (P <0.001).
The ranges (mean ± 2 SD) for total plasma and serum cysteine in men were 152.8 to 266.5 and 198.4 to 335.3 jmol/L, respectively, and 135.8 to 245.7 and 165.1 to 295.9 .imol/L, respectively, in women. The differences between mean plasma and serum cysteine concentrations by sex were also significant ( Table 1) : P = 0.006 for plasma and P <0.001 for serum.
Cysteinyiglycine. The plasma and serum values for total CysGly were normally distributed in both sexes. In men the means (±SD) in plasma and serum were 30.79 Table 1) . The means (±SD) for total plasma and serum cysteine in women were 26.53 (±3.65) and 34.10 (±4.32) anol/L, respectively, marginally significant (P = 0.022), and the mean ± 2 SD ranges were 19.24-33.82 and 25. 47-42.74 mol/L, respectively. The sex-related differences between mean total plasma and serum CysGly were highly significant (Table 1) : P <0.001 for both plasma and serum. 
DIscussion
The aims of this study were to establish a rapid and 'accurate assay for total homocysteine and other lowmolecular-mass The thiol-bimane standards are useful for assessing the performance of the chromatography system and are routinely incorporated at the beginning and end of each patient run. The availability of highly purified thiol-bimane standards has made it possible to characterize the spectrophotometric properties of these compounds. The four standards had very similar absorbance spectra, with peaks at 234, 256, and 389 nm. The fluorescence excitation and emission spectra of the four compounds were also very similar, with excitation and emission maxima occurring at 390-392 and 478-480 nm, respectively.
There were only minor differences in the relative quantum yields of the four thiol-bimane standards.
Total homocysteine, cysteine, and CysGly were determined in serum and plasma obtained from healthy fast-ing donors. To standardize conditions for this study, we obtained the serum and plasma specimens from each donor at the same time, and the EDTA plasma specimen was collected in a chilled tube, placed on ice, and processed within 15 miii at 4#{176}C. The serum specimen was obtained from blood that had been allowed to clot for precisely 1 h at room temperature (22-23#{176}C here plasma homocysteine may be a highly sensitive indicator of both cobalamin and folic acid status, not only in patients with frank deficiencies of these vitamins, but in "normal" individuals as well. We are currently studying the effect of both cobalamin and folate supplementation in these donors to see whether total plasma homocysteine concentrations can be significantly lowered.
In conclusion, this rapid assay for total homocysteine, cysteine, and CysGly in plasma and serum is highly sensitive and precise and has the capability of high sample throughput.
Using this assay, we have been able to accurately establish 
